Product Information
CARBIDOPA-LEVO 25-100 MG ODT is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $0.6971 per EA under NDC 47335018788. Its NADAC has been published 519 times since Jul 15, 2015.
FDA first approved this application on Jul 31, 2009. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
25; 100 mg/1; mg/1
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
47335018788
Classification
Generic
Dosage Form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
CARBIDOPA; LEVODOPAApproval Type
Generic (ANDA)
FDA Application
ANDA078690FDA Approved
7/31/2009
TE Code
AB
On Market Since
12/15/2014
Pharmacological Classes
Price Statistics
The NADAC for CARBIDOPA-LEVO 25-100 MG ODT has been published 519 times since Jul 15, 2015, and over the history we have for it it has declined 24.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6971 per EA |
|---|---|
| All-time high | $0.9246 (Jan 13, 2016) |
| All-time low | $0.6239 (Jun 23, 2021) |
| 52-week high | $0.8197 |
| 52-week low | $0.6971 |
| Median price | $0.7479 |
| Average price | $0.7588 |
| Largest weekly change | +18.7% (May 20, 2020) |
| Weeks tracked | 519 |
| Tracking since | Jul 15, 2015 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 89% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CARBIDOPA-LEVO 25-100 MG ODT?
The current National Average Drug Acquisition Cost (NADAC) for CARBIDOPA-LEVO 25-100 MG ODT, manufactured by Sun Pharmaceutical Industries Inc., is $0.6971 per EA (NDC 47335018788), effective Aug 19, 2026.
How has the price of CARBIDOPA-LEVO 25-100 MG ODT changed over time?
Over the history we have for it, the NADAC for CARBIDOPA-LEVO 25-100 MG ODT has declined 24.6%. It has been tracked across 519 weekly CMS publications since Jul 15, 2015.
What are the highest and lowest recorded NADAC prices for CARBIDOPA-LEVO 25-100 MG ODT?
Since Jul 15, 2015, the NADAC for CARBIDOPA-LEVO 25-100 MG ODT has ranged from a low of $0.6239 (Jun 23, 2021) to a high of $0.9246 (Jan 13, 2016), with a median of $0.7479 per EA.
Are there cheaper alternatives to CARBIDOPA-LEVO 25-100 MG ODT?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CARBIDOPA-LEVODOPA 25-100 TAB, is $0.0757 per EA — about 89% below CARBIDOPA-LEVO 25-100 MG ODT.
Who manufactures CARBIDOPA-LEVO 25-100 MG ODT?
CARBIDOPA-LEVO 25-100 MG ODT (NDC 47335018788) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.